The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study

R-Bendamustine is an effective treatment for follicular lymphoma (FL). Previous large trials demonstrated the prognostic role of the molecular minimal residual disease (MRD) during the most frequently adopted chemotherapeutic regimens, but there are not yet conclusive data about the effect of combin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Galimberti, Sara, Ciabatti, Elena, Ercolano, Giacomo, Grassi, Susanna, Guerrini, Francesca, Cecconi, Nadia, Rousseau, Martina, Cervetti, Giulia, Mazziotta, Francesco, Iovino, Lorenzo, Falzetti, Franca, Falcinelli, Flavio, Bosi, Alberto, Rigacci, Luigi, Kovalchuk, Sofia, Vallisa, Daniele, Macchia, Lucia, Ciancia, Eugenio, Petrini, Mario
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2017
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5489595/
https://ncbi.nlm.nih.gov/pubmed/28706485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00413
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak